Treatment results of preoperative concurrent chemoradiotherapy followed by surgery for stage III or IV esophageal squamous cell carcinoma

Radiation Medicine - Medical Imaging and Radiation Oncology

Volumn 24, Issue 1, 2006, Pages 65-71

  Yamashita, Hideomi ^a   Nakagawa, Keiichi ^a   Tago, Masao ^a   Nakamura, Naoki ^a   Shiraishi, Kenshiro ^a   Mafune, Ken Ichi ^a   Kaminishi, Michio ^a   Ohtomo, Kuni ^a  

^a UNIVERSITY OF TOKYO HOSPITAL   (Japan)

Author keywords

Esophageal cancer; Preoperative chemoradiotherapy; Surgery

Indexed keywords

CISPLATIN; FLUOROURACIL;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BOLUS INJECTION; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CLINICAL ARTICLE; CONTINUOUS INFUSION; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; HEMATOLOGIC DISEASE; HEMATOMA; HUMAN; HUMAN TISSUE; MALE; MEDIASTINITIS; MULTIMODALITY CANCER THERAPY; PATHOLOGY; PNEUMONIA; PREOPERATIVE TREATMENT; PROGNOSIS; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CISPLATIN; COMBINED MODALITY THERAPY; ESOPHAGEAL NEOPLASMS; FEMALE; FLUOROURACIL; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; RADIOTHERAPY DOSAGE; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 32844465330     PISSN: 02882043     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02489991     Document Type: Article

References (36)

1. Bhansali MS, Fujita H, Kakegawa T, et al. Pattern of recurrence after extended radical esophagectomy with three-field lymph node dissection for squamous cell carcinoma in the thoracic esophagus. World J Surg, 21: 275-281, 1997.
2. Fink U, Stein HJ, Bochtler H, Roder JD, Wilke HJ, Siewert JR. Neoadjuvant therapy for squamous cell esophageal carcinoma. Ann Oncol, 5 (Suppl 3): 17-26, 1994.
3. Histopathologic criteria for the effects of radiation or anticancer chemotherapy. In Guidelines for Clinical and Pathologic Studies on Carcinoma of the Esophagus, 9th ed. The Japanese Society for Esophageal Disease. (Isono K ed.; Kanehara Shuppan, Tokyo), pp. 55, 1999.
4. National Cancer Institute Common Toxicity Criteria (NCI-CTC) Japan Clinical Oncology Group. Version 2.0, April 30, 1999.
5. Gomi K, Oguchi M, Hirokawa Y, et al. Process and preliminary outcome of a patterns-of-care study of esophageal cancer in Japan: patients treated with surgery and radiotherapy. Int J Radiat Oncol Biol Phys, 56: 813-822, 2003.
6. Coia LR, Minsky BD, Berkey BA, et al. Outcome of patients receiving radiation for cancer of the esophagus: results of the 1992-1994 Patterns of Care Study. J Clin Oncol, 18:455-462, 2000.
7. Kelsen DP, Bains M, Burt M. Neoadjuvant chemotherapy and surgery of cancer of the esophagus. Semin Surg Oncol, 6: 268-273, 1990.
8. Coia LR, Engstrom PF, Paul AR, Stafford PM, Hanks GE. Long-term results of infusional 5-FU, mitomycin-C and radiation as primary management of esophageal carcinoma. Int J Radiat Oncol Biol Phys, 20: 29-36, 1991.
9. Launois B, Delarue D, Campion JP, Kerbaol M. Preoperative radiotherapy for carcinoma of the esophagus. Surg Gynecol Obstet, 153: 690-692, 1981.
10. Gignoux M, Roussel A, Paillot B, et al. The value of preoperative radiotherapy in esophageal cancer: results of a study of the E.O.R.T.C. World J Surg, 11: 426-432, 1987.
11. Wang M, Gu XZ, Yin WB, Huang GJ, Wang LJ, Zhang DW. Randomized clinical trial on the combination of preoperative irradiation and surgery in the treatment of esophageal carcinoma: report on 206 patients. Int J Radiat Oncol Biol Phys, 16: 325-327, 1989.
12. Arnott SJ, Duncan W, Kerr GR, et al. Low dose pre-operative radiotherapy for carcinoma of the oesophagus: results of a randomized clinical trial. Radiother Oncol, 24: 108-113, 1992.
13. Teniere P, Hay JM, Fingerhut A, Fagniez PL. Post-operative radiation therapy does not increase survival after curative resection for squamous cell carcinoma of the middle and lower esophagus as shown by a multicenter controlled trial. French University Association for Surgical Research. Surg Gynecol Obstet, 173: 123-130, 1991.
14. Fok M, Sham JS, Choy D, Cheng SW, Wong J. Post-operative radiotherapy for carcinoma of the esophagus: a prospective, randomized controlled study. Surgery, 113: 138-147, 1993.
15. Roth JA, Pass HI, Flanagan MM, Graeber GM, Rosenberg JC, Steinberg S. Randomized clinical trial of preoperative and postoperative adjuvant chemotherapy with cisplatin, vindesine, and bleomycin for carcinoma of the esophagus. J Thorac Cardiovasc Surg, 96: 242-248, 1988.
16. Schlag PM. Randomized trial of preoperative chemotherapy for squamous cell cancer of the esophagus. The Chirurgische Arbeitsgemeinschaft Fuer Onkologie der Deutschen Gesellschaft Fuer Chirurgie Study Group. Arch Surg, 127: 1446-1450, 1992.
17. Fok M, Wong J. Prospective randomized study of preoperative chemotherapy in the treatment of resectable esophageal carcinoma. In Abstract book of the Fifth World Congress of the International Society for Diseases of the Esophagus (Kyoto), pp. 149, 1992.
18. Kok T, Tilanus H, Obertop H, et al. Neoadjuvant chemotherapy in operable esophageal squamous cell cancer: an interim report of a randomized controlled trial. In Abstract book of the Fifth World Congress of the International Society for Diseases of the Esophagus (Kyoto), pp. 38, 1992.
19. Nygaard K, Hagen S, Hansen HS, et al. Pre-operative radiotherapy prolongs survival in operable esophageal carcinoma: a randomized, multicenter study of pre-operative radiotherapy and chemotherapy. The second Scandinavian trial in esophageal cancer. World J Surg, 16: 1104-1110, 1992.
20. Le Prise E, Etienne PL, Meunier B, et al. A randomized study of chemotherapy, radiation therapy, and surgery versus surgery for localized squamous cell carcinoma of the esophagus. Cancer, 73: 1779-1784, 1994.
21. Urba S, Orringer M, Turrisi A, et al. A randomized trial comparing transhiatal esophagectomy (THE) to pre-operative concurrent chemoradiation (CT/XRT) followed by esophagectomy in locoregional esophageal carcinoma (CA). Proc Am Soc Clin Oncol, 14: 475, 1995.
22. Walsh TN, Noonan N, Hollywood D, Kelly A, Keeling N, Hennessy TP. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med, 335: 462-467, 1996.
23. Bedenne L, Michel P, Bouche O, et al. Randomized phase III trial in locally advanced esophageal cancer: radiochemotherapy followed by surgery versus radiochemotherapy alone (FFCD 9102). Proc Am Soc Clin Oncol, 21: 130a, 2002.
24. Stahl M, Stuschke M, Lehmann N, et al. Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. J Clin Oncol, 23: 2310-2317, 2005.
25. Minsky BD, Pajak TF, Ginsberg RJ, et al. INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy. J Clin Oncol, 20: 1167-1174, 2002.
26. Forastiere AA, Heitmiller RF, Kleinberg L. Multimodality therapy for esophageal cancer. Chest, 112 (4 Suppl): S195-S200, 1997.
27. Urba SG, Orringer MB, Turrisi A, Iannettoni M, Forastiere A, Strawderman M. Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. J Clin Oncol, 19: 305-313, 2001.
28. Forastiere AA, Orringer MB, Perez-Tamayo C, et al. Concurrent chemotherapy and radiation therapy followed by transhiatal esophagectomy for local-regional cancer of the esophagus. J Clin Oncol, 8: 119-127, 1990.
29. Forastiere AA, Orringer MB, Perez-Tamayo C, Urba SG, Zahurak M. Preoperative chemoradiation followed by transhiatal esophagectomy for carcinoma of the esophagus: final report. J Clin Oncol, 11: 1118-1123, 1993.
30. Poplin E, Fleming T, Leichman L, et al. Combined therapies for squamous-cell carcinoma of the esophagus, a Southwest Oncology Group (SWOG-8037). J Clin Oncol, 5: 622-628, 1987.
31. Naunheim KS, Petruska PJ, Roy TS, Schlueter JM, Kim H, Baue AE. Multimodality therapy for adenocarcinoma of the esophagus. Ann Thorac Surg, 59: 1085-1091, 1995.
32. Adelstein DJ, Rice TW, Becker M, et al. Use of concurrent chemotherapy, accelerated fractionation radiation, and surgery for patients with esophageal carcinoma. Cancer, 80: 1011-1020, 1997.
33. Forastiere AA, Heitmiller RF, Lee DJ, et al. Intensive chemoradiation followed by esophagectomy for squamous cell and adenocarcinoma of the esophagus. Cancer J Sci Am, 3: 144-152, 1997.
34. Ohtsu A, Yoshida S, Boku N, et al. Concurrent chemotherapy and radiation therapy for locally advanced carcinoma of the esophagus. Jpn J Clin Oncol, 25: 261-266, 1995.
35. Ohtsu A, Boku N, Muro K, et al. Definitive chemoradiotherapy for T4 and/or M1 lymph node squamous cell carcinoma of the esophagus. J Clin Oncol, 17: 2915-2921, 1999.
36. Nishimura Y, Suzuki M, Nakamatsu K, Kanamori S, Yagyu Y, Shigeoka H. Prospective trial of concurrent chemoradiotherapy with protracted infusion of 5-fluorouracil and cisplatin for T4 esophageal cancer with or without fistula. Int J Radiat Oncol Biol Phys, 53: 134-139, 2002.